comparemela.com

Latest Breaking News On - Cell programs - Page 4 : comparemela.com

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2022 Financial Results

Ginkgo Bioworks Provides Preliminary Unaudited 2022 Revenue Highlights and Business Review

Expects to meet 2022 guidance ranges for Total revenue and new Cell Programs Year end cash balance of approximately $1.3 billion provides ample liquidity and.

vimarsana © 2020. All Rights Reserved.